Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLMT
1876
DELISTED
BSB Bancorp, Inc.
BLMT
| $1.49M | ﹤0.01% |
86,900
+11,408
| +15% | +$199K |
|
|
XL
1877
DELISTED
XL Group Ltd.
XL
| $1.49M | ﹤0.01% |
+45,500
| New | +$1.46M |
|
|
GOOD
1878
Gladstone Commercial Corp
GOOD
$628M
| $1.48M | ﹤0.01% |
83,070
+19,256
| +30% | +$338K |
|
1879
Ormat Technologies
ORA
$7.08B
| $1.48M | ﹤0.01% |
51,457
+5,477
| +12% | +$156K |
|
|
STML
1880
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.48M | ﹤0.01% |
+101,052
| New | +$1.55M |
|
|
CHSP
1881
DELISTED
Chesapeake Lodging Trust
CHSP
| $1.48M | ﹤0.01% |
48,900
+38,311
| +362% | +$1.08M |
|
1882
Aviat Networks
AVNW
$285M
| $1.48M | ﹤0.01% |
192,142
+18,368
| +11% | +$141K |
|
|
SGMA
1883
DELISTED
Sigmatron International
SGMA
| $1.48M | ﹤0.01% |
122,400
+20,900
| +21% | +$225K |
|
1884
Home Bancorp
HBCP
$569M
| $1.47M | ﹤0.01% |
66,700
+14,200
| +27% | +$290K |
|
|
CCRN
1885
DELISTED
Cross Country Healthcare
CCRN
| $1.47M | ﹤0.01% |
225,200
-297,402
| -57% | -$1.97M |
|
1886
Universal Electronics
UEIC
$68.3M
| $1.47M | ﹤0.01% |
+30,023
| New | +$1.24M |
|
|
CUNB
1887
DELISTED
CU Bancorp
CUNB
| $1.47M | ﹤0.01% |
77,000
+38,500
| +100% | +$712K |
|
1888
Air T
AIRT
$79.6M
| $1.46M | ﹤0.01% |
168,600
+5,700
| +3% | +$46.2K |
|
|
ESSA
1889
DELISTED
ESSA Bancorp
ESSA
| $1.46M | ﹤0.01% |
130,900
+7,697
| +6% | +$81.9K |
|
1890
Standard BioTools
LAB
$285M
| $1.46M | ﹤0.01% |
+49,500
| New | +$1.59M |
|
|
SBSA
1891
DELISTED
Spanish Broadcasting System Inc.
SBSA
| $1.45M | ﹤0.01% |
251,520
+12,300
| +5% | +$74.5K |
|
1892
Peapack-Gladstone Financial
PGC
$820M
| $1.45M | ﹤0.01% |
68,320
-5,147
| -7% | -$101K |
|
|
AFH
1893
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
| $1.45M | ﹤0.01% |
95,300
+71,593
| +302% | +$1.05M |
|
|
SWSH
1894
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
| $1.44M | ﹤0.01% |
335,359
+124,675
| +59% | +$496K |
|
|
PHLT
1895
DELISTED
Performant Healthcare Inc
PHLT
| $1.43M | ﹤0.01% |
141,887
-196,908
| -58% | -$1.8M |
|
|
FRBK
1896
DELISTED
Republic First Bancorp Inc
FRBK
| $1.43M | ﹤0.01% |
283,896
+44,977
| +19% | +$206K |
|
|
GSS
1897
DELISTED
Golden Star Resources Ltd.
GSS
| $1.43M | ﹤0.01% |
484,480
+47,620
| +11% | +$137K |
|
1898
Asure Software
ASUR
$247M
| $1.43M | ﹤0.01% |
236,376
+700
| +0.3% | +$4.3K |
|
|
PTX
1899
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $1.42M | ﹤0.01% |
+15,764
| New | +$966K |
|
|
FRED
1900
DELISTED
Fred's Inc
FRED
| $1.42M | ﹤0.01% |
+92,550
| New | +$1.55M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.